These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30264829)

  • 1. New insights from IeDEA and COHERE on global trends in CD4 counts at ART initiation.
    Yendewa GA
    AIDS Rev; 2018; 20(3):174-175. PubMed ID: 30264829
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the need for ART being grossly underestimated?
    England R
    Lancet; 2006 Jul; 368(9532):281. PubMed ID: 16860686
    [No Abstract]   [Full Text] [Related]  

  • 3. Zero CD4 count: a case of discordant CD4 response in a patient with well suppressed viral load.
    Raja K; Chandrasekar C; Krishnarajasekhar OR; Manoharan G
    Indian J Med Microbiol; 2013; 31(3):298-302. PubMed ID: 23883722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
    Sun J; Liu L; Shen J; Chen P; Lu H
    BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
    Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
    HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus.
    Bishop JD; DeShields S; Cunningham T; Troy SB
    Am J Med Sci; 2016 Sep; 352(3):239-44. PubMed ID: 27650226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011.
    Hsu LC; Truong HM; Vittinghoff E; Zhi Q; Scheer S; Schwarcz S
    J Infect Dis; 2014 May; 209(9):1310-4. PubMed ID: 24218501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does antiretroviral therapy started at high CD4 cell counts reduce an individual HIV-positive patient's disease risk?
    Baker JV; Sabin CA
    Curr Opin HIV AIDS; 2014 Jan; 9(1):1-3. PubMed ID: 24225383
    [No Abstract]   [Full Text] [Related]  

  • 15. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in absolute CD4 count with antiretroviral treatment in resource limited setting: a retrospective cohort study in children in Ethiopia.
    Berhan Y
    Ethiop Med J; 2011 Oct; 49(4):289-98. PubMed ID: 23409394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing tuberculosis in differentiated care provision for people living with HIV.
    Pathmanathan I; Pevzner E; Cavanaugh J; Nelson L
    Bull World Health Organ; 2017 Jan; 95(1):3. PubMed ID: 28053356
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.
    Auld AF; Shiraishi RW; Oboho I; Ross C; Bateganya M; Pelletier V; Dee J; Francois K; Duval N; Antoine M; Delcher C; Desforges G; Griswold M; Domercant JW; Joseph N; Deyde V; Desir Y; Van Onacker JD; Robin E; Chun H; Zulu I; Pathmanathan I; Dokubo EK; Lloyd S; Pati R; Kaplan J; Raizes E; Spira T; Mitruka K; Couto A; Gudo ES; Mbofana F; Briggs M; Alfredo C; Xavier C; Vergara A; Hamunime N; Agolory S; Mutandi G; Shoopala NN; Sawadogo S; Baughman AL; Bashorun A; Dalhatu I; Swaminathan M; Onotu D; Odafe S; Abiri OO; Debem HH; Tomlinson H; Okello V; Preko P; Ao T; Ryan C; Bicego G; Ehrenkranz P; Kamiru H; Nuwagaba-Biribonwoha H; Kwesigabo G; Ramadhani AA; Ng'wangu K; Swai P; Mfaume M; Gongo R; Carpenter D; Mastro TD; Hamilton C; Denison J; Wabwire-Mangen F; Koole O; Torpey K; Williams SG; Colebunders R; Kalamya JN; Namale A; Adler MR; Mugisa B; Gupta S; Tsui S; van Praag E; Nguyen DB; Lyss S; Le Y; Abdul-Quader AS; Do NT; Mulenga M; Hachizovu S; Mugurungi O; Barr BAT; Gonese E; Mutasa-Apollo T; Balachandra S; Behel S; Bingham T; Mackellar D; Lowrance D; Ellerbrock TV
    MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(21):558-563. PubMed ID: 28570507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
    Chêne G; Phillips A; Costagliola D; Sterne JAC; Furrer H; Del Amo J; Mocroft A; d'Arminio Monforte A; Dabis F; Miro JM; Barger D; Termote M; Schwimmer C; Salbøl Brandt R; Friis-Moller N; Raben D; Haerry D; Egger M; Weller I; De Wit S
    Int J Epidemiol; 2017 Jun; 46(3):797-797n. PubMed ID: 27864413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
    Bigna JJ; Plottel CS; Koulla-Shiro S
    Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.